Agilent Technologies, Inc. (NYSE:A) Given Average Rating of “Moderate Buy” by Analysts

Shares of Agilent Technologies, Inc. (NYSE:A) have received an average rating of “Moderate Buy” from the twenty ratings firms that are covering the company, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $170.3333.

Several equities analysts have recently issued reports on A shares. Wells Fargo & Company lowered their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Thursday, May 28th. Sanford C. Bernstein raised their target price on shares of Agilent Technologies from $155.00 to $180.00 and gave the stock an “outperform” rating in a report on Thursday, August 27th. Piper Sandler assumed coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 price target on the stock. HSBC dropped their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Finally, Citigroup raised their price objective on Agilent Technologies from $185.00 to $190.00 and gave the stock a “buy” rating in a research note on Thursday, August 27th.

Institutional Investors Weigh In On Agilent Technologies

A number of institutional investors have recently bought and sold shares of the business. California State Teachers Retirement System grew its position in Agilent Technologies by 12,343.3% during the second quarter. California State Teachers Retirement System now owns 54,577,058 shares of the medical research company’s stock valued at $7,249,471,000 after purchasing an additional 54,138,451 shares in the last quarter. State Street Corp lifted its position in Agilent Technologies by 1.9% in the 4th quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock worth $1,725,611,000 after buying an additional 241,029 shares in the last quarter. Wellington Management Group LLP boosted its stake in shares of Agilent Technologies by 2.7% during the 2nd quarter. Wellington Management Group LLP now owns 7,454,686 shares of the medical research company’s stock valued at $990,206,000 after buying an additional 198,253 shares during the period. Geode Capital Management LLC grew its holdings in shares of Agilent Technologies by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock valued at $1,006,519,000 after acquiring an additional 25,139 shares in the last quarter. Finally, Deutsche Bank AG grew its holdings in shares of Agilent Technologies by 17.1% during the 2nd quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock valued at $930,957,000 after acquiring an additional 1,024,516 shares in the last quarter.

Agilent Technologies Stock Down 0.0%

A stock opened at $153.79 on Tuesday. The firm’s 50-day moving average is $140.85 and its two-hundred day moving average is $127.21. The company has a market capitalization of $43.43 billion, a price-to-earnings ratio of 30.27, a price-to-earnings-growth ratio of 2.34 and a beta of 1.25. Agilent Technologies has a 52 week low of $108.35 and a 52 week high of $163.75. The company has a current ratio of 2.05, a quick ratio of 1.56 and a debt-to-equity ratio of 0.50.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The company had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.84 billion. During the same period last year, the firm earned $1.37 EPS. The firm’s revenue for the quarter was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, analysts forecast that Agilent Technologies will post 6.2 earnings per share for the current fiscal year.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.